FinTrust Capital Advisors’s Medifast MED Stock Holding History

FinTrust Capital Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-155	Closed	-$17.9K	–	1296
2023 Q2	$17.9K	Hold	155	–	–	﹤0.01%	675
2023 Q1	$17.9K	Hold	155	–	–	﹤0.01%	673
2022 Q4	$17.9K	Hold	155	–	–	﹤0.01%	670
2022 Q3	$19K	Buy	155 +6	+4%	+$860	﹤0.01%	729
2022 Q2	$26K	Buy	149 +24	+19%	+$4.29K	0.01%	666
2022 Q1	$21K	Hold	125	–	–	﹤0.01%	756
2021 Q4	$26K	Hold	125	–	–	0.01%	668
2021 Q3	$24K	Hold	125	–	–	0.01%	692
2021 Q2	$35K	Hold	125	–	–	0.01%	621
2021 Q1	$26K	Sell	125 -46	-27%	-$11K	0.01%	654
2020 Q4	$34K	Sell	171 -47	-22%	-$8.31K	0.01%	557
2020 Q3	$36K	Sell	218 -334	-61%	-$55K	0.01%	550
2020 Q2	$77K	Buy	552 +275	+99%	+$25.2K	0.03%	392
2020 Q1	$17K	Buy	277 +122	+79%	+$11.1K	0.01%	661
2019 Q4	$17K	Sell	155 -138	-47%	-$13.4K	0.01%	669
2019 Q3	$30K	Buy	+293	New	+$31.5K	0.01%	562

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FinTrust Capital Advisors's MED Position: Q3 2023 in Review

FinTrust Capital Advisors sold out of Medifast (MED) in Q3 2023, closing a stake of 155 shares — an estimated $17.9K sold.

FinTrust Capital Advisors first reported a position in MED in Q3 2019 and held it in 16 quarters. The position peaked at $77K in Q2 2020. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

FinTrust Capital Advisors reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
FinTrust Capital Advisors sold 155 Medifast shares in Q3 2023, an estimated $17.9K.
FinTrust Capital Advisors first reported a position in Medifast in Q3 2019 and held it in 16 quarters.
FinTrust Capital Advisors's Medifast position peaked at $77K in Q2 2020.
223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on FinTrust Capital Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.